SUZANNE JAN DE BEUR, M.D.
Osteopathic Medicine at Wolfe St, Baltimore, MD
License number
Maryland D52037
Category
Osteopathic Medicine
Type
Endocrinology, Diabetes & Metabolism
Address
Address
600 N Wolfe St, Baltimore, MD 21287
Phone
(410) 955-9270
(410) 550-2663
(410) 550-2663
Personal information
See more information about SUZANNE JAN DE BEUR at radaris.comName
Address
Phone
5510 Roland Ave, Baltimore, MD 21210
Organization information
See more information about SUZANNE JAN DE BEUR at bizstanding.comSuzanne Jan De Beur MD
600 N Wolfe St, Baltimore, MD 21287
Industry:
Endocrinologist, Internist
Phone:
(410) 955-9270 (Phone)
Suzanne Marie Jan De Beur
Professional information
See more information about SUZANNE JAN DE BEUR at trustoria.com
Associate Professor Of Medicine At Johns Hopkins School Of Medicine
Associate Professor Of Medicine At Johns Hopkins School Of Medicine
Location:
Baltimore, Maryland Area
Industry:
Research
Associate Professor Of Medicine At Johns Hopkins School Of Medicine
Associate Professor Of Medicine At Johns Hopkins School Of Medicine
Location:
Baltimore, Maryland Area
Industry:
Medical Practice
Oncogenic Osteomalacia-Related Gene 1
Oncogenic Osteomalacia-Related Gene 1
US Patent:
2002010, Aug 1, 2002
Filed:
Mar 22, 2001
Appl. No.:
09/814550
Inventors:
Susan Schia Vi - Hopkinton MA, US
Stephen Madden - Sudbury MA, US
Parthasarathy Manavalan - Medway MA, US
Michael Levine - Owings Mills MD, US
Suzanne Jan De Beur - Baltimore MD, US
Stephen Madden - Sudbury MA, US
Parthasarathy Manavalan - Medway MA, US
Michael Levine - Owings Mills MD, US
Suzanne Jan De Beur - Baltimore MD, US
International Classification:
C12P021/02, C07H021/04, C12N009/10
US Classification:
435/069100, 435/193000, 435/325000, 435/320100, 536/023200
Abstract:
This invention provides isolated polynucleotides encoding an oncogenic osteomalacia-related factor and polypeptides encoded by this polynucleotide. Expression systems, including gene delivery vehicles such as liposomes and vectors, and host cells containing the polynucleotides are further provided by this invention. The present invention also provides proteins encoded by the polynucleotides and antibodies that specifically recognize and bind to these proteins. In one embodiment the proteins that modulate bone mineralization and phosphate metabolism as characterized by the methods described herein. The present invention also provides methods for modulating bone mineralization activity and phosphate metabolism and for treating diseases related to abnormal bone mineralization and abnormal phosphate metabolism.